(Q53355934)

13 May 2018

title

Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry. (English)

1 reference

13 May 2018

main subject

Alzheimer's disease

0 references

metabolomic profiling

1 reference

inferred from title

author

Raúl González-Domínguez

1

1 reference

13 May 2018

Tamara García-Barrera

3

1 reference

13 May 2018

José Luis Gómez-Ariza

5

1 reference

13 May 2018

Coral Barbas

object named as

Coral Barbas

4

0 references

author name string

Antonia García

2

1 reference

13 May 2018

publication date

9 October 2014

1 reference

13 May 2018

published in

Electrophoresis

1 reference

13 May 2018

volume

35

1 reference

13 May 2018

issue

23

1 reference

13 May 2018

page(s)

3321-3330

1 reference

13 May 2018

describes a project that uses

capillary electrophoresis

1 reference

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Current concepts in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Health co-morbidities in ageing persons with Down syndrome and Alzheimer's dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Brain imaging in the study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Inflammation and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabonomics and its role in drug development and disease diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

A possible new diagnostic biomarker in early diagnosis of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Quantitative profiling of polar cationic metabolites in human cerebrospinal fluid by reversed-phase nanoliquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

A new metabolomic workflow for early detection of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolomic changes in autopsy-confirmed Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Alterations in metabolic pathways and networks in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolite profiling of Alzheimer's disease cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Plasma metabolic profiling of Alzheimer's disease by liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolome in progression to Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

A multi-metabolite analysis of serum by 1H NMR spectroscopy: early systemic signs of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolomic study of lipids in serum for biomarker discovery in Alzheimer's disease using direct infusion mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Analysis of chiral amino acids in cerebrospinal fluid samples linked to different stages of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Combination of metabolomic and phospholipid-profiling approaches for the study of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Quantitative and wide-ranging profiling of phospholipids in human plasma by two-dimensional liquid chromatography/mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Capillary electrophoresis as a metabolomics tool for non-targeted fingerprinting of biological samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Metabolome analysis by capillary electrophoresis-mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Toward a predictive model of Alzheimer's disease progression using capillary electrophoresis-mass spectrometry metabolomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Mild cognitive impairment as a diagnostic entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

A pragmatic and readily implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Programmed nebulizing gas pressure for efficient and stable capillary electrophoresis-mass spectrometry analysis of anionic compounds in positive separation mode.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Centering, scaling, and transformations: improving the biological information content of metabolomics data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Plasma metabolite profiles of Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Decreased plasma antioxidants in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Hippocampal proton MR spectroscopy in early Alzheimer's disease and mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Cerebrospinal fluid carnitine levels in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

The clinical manifestation of MCAD deficiency: challenges towards adulthood in the screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Multiple defects in energy metabolism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

3-Hydroxyacyl-CoA dehydrogenase and short chain 3-hydroxyacyl-CoA dehydrogenase in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Longitudinal metabolic and cognitive changes in mild cognitive impairment patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Glycerophosphocholine is elevated in cerebrospinal fluid of Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

One-carbon metabolism and Alzheimer's disease: focus on epigenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

S-adenosylmethionine is decreased in the cerebrospinal fluid of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Cerebrospinal fluid levels of non-neurotransmitter amino acids in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Alzheimer's disease: amino acid levels and brain metabolic status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Measurement of homocysteine and related metabolites in human plasma and urine by liquid chromatography electrospray tandem mass spectrometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Hyperhomocysteinemia and Alzheimer's disease: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Asymmetrical dimethylarginine is increased in plasma and decreased in cerebrospinal fluid of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Role of spermine in amyloid beta-peptide-associated free radical-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Polyamines in frontal cortex of patients with Down syndrome and Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Mining the unknown: a systems approach to metabolite identification combining genetic and metabolic information

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Angiotensins in Alzheimer's disease - friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Proteases and proteolysis in Alzheimer disease: a multifactorial view on the disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Biomarkers for Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Comprehensive plasma thiol redox status determination for metabolomics

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Method development and validation for rat serum fingerprinting with CE–MS: application to ventilator-induced-lung-injury study

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Effect of a nutraceutical treatment on diabetic rats with targeted and CE-MS non-targeted approaches

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Role of oxidative stress in the progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Mitochondrial dysfunction and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Brain S-adenosylmethionine levels are severely decreased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Brain polyamine levels are altered in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Urinary polyamines and N-acetylated polyamines in four patients with Alzheimer's disease as their N-ethoxycarbonyl-N-pentafluoropropionyl derivatives by gas chromatography-mass spectrometry in selected ion monitoring mode

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Serum 27-nor-5β-cholestane-3,7,12,24,25 pentol glucuronide discovered by metabolomics as potential diagnostic biomarker for epithelium ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

LC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohort

1 reference

https://api.crossref.org/works/10.1002%2FELPS.201400196

7 January 2021

Identifiers

DOI

10.1002/ELPS.201400196

1 reference

13 May 2018

1 reference

13 May 2018